BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32698129)

  • 1. Reducing hepatic PKD activity lowers circulating VLDL cholesterol.
    Genders AJ; Connor T; Morrison S; Bond ST; Drew BG; Meikle PJ; Howlett KF; McGee SL
    J Endocrinol; 2020 Sep; 246(3):265-276. PubMed ID: 32698129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CTRP1 disrupts glucose and lipid homeostasis.
    Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of protein kinase D activity demonstrates redundancy in cardiac glucose metabolism and preserves cardiac function in obesity.
    De Jong KA; Hall LG; Renton MC; Connor T; Martin SD; Kowalski GM; Shaw CS; Bruce CR; Howlett KF; McGee SL
    Mol Metab; 2020 Dec; 42():101105. PubMed ID: 33099046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.
    Singh AB; Kan CFK; Kraemer FB; Sobel RA; Liu J
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E880-E894. PubMed ID: 30721098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
    Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
    Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
    Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of IL-6 improves indices of hepatic glucose and insulin homeostasis in lean and obese mice.
    Peppler WT; Townsend LK; Meers GM; Panasevich MR; MacPherson REK; Rector RS; Wright DC
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G166-G178. PubMed ID: 30383412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
    Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
    Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
    Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
    Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.
    Hebel T; Eisinger K; Neumeier M; Rein-Fischboeck L; Pohl R; Meier EM; Boettcher A; Froehner SC; Adams ME; Liebisch G; Krautbauer S; Buechler C
    Biochim Biophys Acta; 2015 May; 1851(5):527-36. PubMed ID: 25625330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
    Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
    Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.